Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Geriatric Medicines market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Geriatric Medicines market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Geriatric Medicines market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Geriatric Medicines products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Geriatric Medicines products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Geriatric Medicines market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Geriatric Medicines development has been the leading industry trend of Geriatric Medicines market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Geriatric Medicines Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Analgesics, Antihypertensives, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotics, Antidepressants |
| By Application Outlook |
Cardiovascular diseases, Arthritis, Neurological Disorders, Cancer, Osteoporosis, Respiratory |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Eli Lilly and Company, AstraZeneca, Boehringer Ingelheim, Abbott Laboratories, Sanofi, Bristol-Myers Squibb, Merck, Novartis, Pfizer, GSK |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Eli Lilly and Company
- AstraZeneca
- Boehringer Ingelheim
- Abbott Laboratories
- Sanofi
- Bristol-Myers Squibb
- Merck
- Novartis
- Pfizer
- GSK
GERIATRIC MEDICINES Market, By Type
- Analgesics
- Antihypertensives
- Statins
- Antidiabetics
- Proton Pump Inhibitor
- Anticoagulant
- Antipsychotics
- Antidepressants
GERIATRIC MEDICINESMarket, By Application
- Cardiovascular diseases
- Arthritis
- Neurological Disorders
- Cancer
- Osteoporosis
- Respiratory
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Geriatric Medicines Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Geriatric Medicines
1.1 Geriatric Medicines Market Overview
1.1.1 Geriatric Medicines Product Scope
1.1.2 Market Status and Outlook
1.2 Global Geriatric Medicines Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Geriatric Medicines Market by Type
1.3.1 Analgesics
1.3.2 Antihypertensives
1.3.3 Statins
1.3.4 Antidiabetics
1.3.5 Proton Pump Inhibitor
1.3.6 Anticoagulant
1.3.7 Antipsychotics
1.3.8 Antidepressants
1.4 Geriatric Medicines Market by End Users/Application
1.4.1 Cardiovascular diseases
1.4.2 Arthritis
1.4.3 Neurological Disorders
1.4.4 Cancer
1.4.5 Osteoporosis
1.4.6 Respiratory
2 Global Geriatric Medicines Competition Analysis by Players
2.1 Geriatric Medicines Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Eli Lilly and Company
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 AstraZeneca
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Boehringer Ingelheim
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Abbott Laboratories
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Sanofi
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Bristol-Myers Squibb
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Merck
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Novartis
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Pfizer
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 GSK
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.10.5 Recent Developments
4 Global Geriatric Medicines Market Size by Type and Application (2014-2019)
4.1 Global Geriatric Medicines Market Size by Type (2014-2019)
4.2 Global Geriatric Medicines Market Size by Application (2014-2019)
4.3 Potential Application of Geriatric Medicines in Future
4.4 Top Consumer/End Users of Geriatric Medicines
5 North America Geriatric Medicines Development Status and Outlook
5.1 North America Geriatric Medicines Market Size (2014-2019)
5.2 North America Geriatric Medicines Market Size and Market Share by Players (2018 and 2019)
6 Europe Geriatric Medicines Development Status and Outlook
6.1 Europe Geriatric Medicines Market Size (2014-2019)
6.2 Europe Geriatric Medicines Market Size and Market Share by Players (2018 and 2019)
7 China Geriatric Medicines Development Status and Outlook
7.1 China Geriatric Medicines Market Size (2014-2019)
7.2 China Geriatric Medicines Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Geriatric Medicines Development Status and Outlook
8.1 Rest of Asia Pacific Geriatric Medicines Market Size (2014-2019)
8.2 Rest of Asia Pacific Geriatric Medicines Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Geriatric Medicines Development Status and Outlook
9.1 Central & South America Geriatric Medicines Market Size (2014-2019)
9.2 Central & South America Geriatric Medicines Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Geriatric Medicines Development Status and Outlook
10.1 Middle East & Africa Geriatric Medicines Market Size (2014-2019)
10.2 Middle East & Africa Geriatric Medicines Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2019-2025)
11.1 Global Geriatric Medicines Market Size (Value) by Regions (2019-2025)
11.1.1 North America Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.2 Europe Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.3 China Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.2 Global Geriatric Medicines Market Size (Value) by Type (2019-2025)
11.3 Global Geriatric Medicines Market Size by Application (2019-2025)
12 Geriatric Medicines Market Dynamics
12.1 Geriatric Medicines Market Opportunities
12.2 Geriatric Medicines Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Geriatric Medicines Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Geriatric Medicines Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
